Polymer-coated nanoparticles for therapeutic and diagnostic non-10b enriched polymer-coated boron carbon oxynitride (Bcno) nanoparticles as potent bnct drug

16Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Boron neutron capture therapy (BNCT) is a powerful and selective anti-cancer therapy utilizing10B-enriched boron drugs. However, clinical advancement of BCNT is hampered by the insufficient loading of B-10 drugs throughout the solid tumor. Furthermore, the preparation of boron drugs for BNCT relies on the use of the costly B-10 enriched precursor. To overcome these challenges, polymer-coated boron carbon oxynitride (BCNO) nanoparticles, with ~30% of boron, were developed with enhanced biocompatibility, cell uptake, and tumoricidal effect via BNCT. Using the ALTS1C1 cancer cell line, the IC50 of the PEG@BCNO, bare, PEI@BCNO were determined to be 0.3 mg/mL, 0.1 mg/mL, and 0.05 mg/mL, respectively. As a proof-of-concept, the engineered non-10B enriched polymer-coated BCNO exhibited excellent anti-tumor effect via BNCT due to their high boron content per nanoparticle and due to the enhanced cellular internalization and retention compared to small molecular10B-BPA drug. The astrocytoma ALTS1C1 cells treated with bare, polyethyleneimine-, and polyethylene glycol-coated BCNO exhibited an acute cell death of 24, 37, and 43%, respectively, upon 30 min of neutron irradiation compared to the negligible cell death in PBS-treated and non-irradiated cells. The radical approach proposed in this study addresses the expensive and complex issues of B-10 isotope enrichment process; thus, enabling the preparation of boron drugs at a significantly lower cost, which will facilitate the development of boron drugs for BNCT.

Cite

CITATION STYLE

APA

Chiang, C. W., Chien, Y. C., Yu, W. J., Ho, C. Y., Wang, C. Y., Wang, T. W., … Keng, P. Y. (2021). Polymer-coated nanoparticles for therapeutic and diagnostic non-10b enriched polymer-coated boron carbon oxynitride (Bcno) nanoparticles as potent bnct drug. Nanomaterials, 11(11). https://doi.org/10.3390/nano11112936

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free